Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
52 hedge funds and large institutions have $62.1M invested in Calithera Biosciences, Inc in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 11 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 54 → 52 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
28% less capital invested
Capital invested by funds: $86.8M → $62.1M (-$24.7M)
97% less call options, than puts
Call options by funds: $3K | Put options by funds: $86K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$275K |
| 2 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$266K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$218K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$213K |
| 5 |
FSA
Franklin Street Advisors
Chapel Hill,
North Carolina
|
+$202K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.18M |
| 2 |
FAM
Fred Alger Management
New York
|
-$643K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$354K |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$287K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$160K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
BlackRock
New York
| $2K | +$906 | +8 | +73% |
|
52
Geode Capital Management
Boston,
Massachusetts
| $376 | +$24.4K | +215 | +7% |
|
|
EC
53
EcoR1 Capital
San Francisco,
California
| – | -$3.18M | -20,774 | Closed |
|
|
FAM
54
Fred Alger Management
New York
| – | -$643K | -4,200 | Closed |
|
|
LCM
55
Landscape Capital Management
Englewood,
New Jersey
| – | -$287K | -1,872 | Closed |
|
|
56
Citadel Advisors
Miami,
Florida
| – | -$160K | -1,044 | Closed |
|
|
BG
57
BlackRock Group
London,
United Kingdom
| – | -$97K | -631 | Closed |
|
58
Squarepoint
New York
| – | -$90K | -585 | Closed |
|
|
MCM
59
Mazama Capital Management
Portland,
Oregon
| – | -$28K | -184 | Closed |
|
60
BNP Paribas Financial Markets
Paris,
France
| – | -$25.4K | -166 | Closed |
|
61
UBS Group
Zurich,
Switzerland
| – | -$19K | -121 | Closed |
|
|
CG
62
Cutler Group
San Francisco,
California
| – | -$13K | -115 | Closed |
|
63
Bank of America
Charlotte,
North Carolina
| – | -$2K | -13 | Closed |
|
CALA Hedge Fund Activity: Q1 2016 in Review
52 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q1 2016, worth a combined $62.1M — down 28% from $86.8M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CALA and 9 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 18 added.
The largest buyer was TFS Capital, opening a new position worth an estimated $275K. The largest seller was EcoR1 Capital, exiting entirely with an estimated $3.18M sold.
- 52 institutional investors held Calithera Biosciences, Inc (CALA) as of Q1 2016, down from 54 in Q4 2015.
- Funds reported $62.1M of Calithera Biosciences, Inc stock for Q1 2016, down 28% quarter-over-quarter.
- 9 funds opened new Calithera Biosciences, Inc positions in Q1 2016 and 11 closed out, a net change of -2 holders.
- The largest Calithera Biosciences, Inc buyer in Q1 2016 was TFS Capital, an estimated $275K added.
- The largest Calithera Biosciences, Inc seller in Q1 2016 was EcoR1 Capital, an estimated $3.18M sold.
Based on aggregated 13F filings for Q1 2016.